Book contents
- 55 Cases in Neurology
- 55 Cases in Neurology
- Copyright page
- Contents
- Preface
- Acknowledgements
- Section 1 Visual Disturbance
- Section 2 Headache and Pain
- Section 3 Weakness
- Section 4 Behavioural and Language Changes
- Section 5 Confusion
- Section 6 Movement Disturbances
- Section 7 Acute Onset of Neurological Symptoms
- Index
- Plate Section (PDF Only)
- References
Section 3 - Weakness
Published online by Cambridge University Press: 27 July 2023
Book contents
- 55 Cases in Neurology
- 55 Cases in Neurology
- Copyright page
- Contents
- Preface
- Acknowledgements
- Section 1 Visual Disturbance
- Section 2 Headache and Pain
- Section 3 Weakness
- Section 4 Behavioural and Language Changes
- Section 5 Confusion
- Section 6 Movement Disturbances
- Section 7 Acute Onset of Neurological Symptoms
- Index
- Plate Section (PDF Only)
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- 55 Cases in NeurologyCase Histories and Patient Perspectives, pp. 125 - 198Publisher: Cambridge University PressPrint publication year: 2023
References
References
Kumar, N. Superficial siderosis: a clinical review. Ann Neurol. 2021;89(6):1068–79.CrossRefGoogle ScholarPubMed
Wilson, D, Chatterjee, F, Farmer, SF et al. Infratentorial superficial siderosis: classification, diagnostic criteria, and rational investigation pathway. Ann Neurol. 2017;81(3):333–43.CrossRefGoogle ScholarPubMed
Kessler, RA, Li, X, Schwartz, K et al. Two-year observational study of deferiprone in superficial siderosis. CNS Neurosci Ther. 2018;24(3):187–92.CrossRefGoogle ScholarPubMed
References
Fratter, C, Raman, P, Alston, CL et al. RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions. Neurology. 2011;76(23):2032–4.CrossRefGoogle ScholarPubMed
McClelland, C, Manousakis, G, Lee, MS. Progressive external ophthalmoplegia. Curr Neurol Neurosci Rep. 2016;16:53.CrossRefGoogle ScholarPubMed
Gorman, GS, Schaefer, AM, Ng, Y et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77(5):753–9.CrossRefGoogle ScholarPubMed
Pitceathly, RDS, Smith, C, Fratter, C et al. Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain. 2012;135(11):3392–403.CrossRefGoogle ScholarPubMed
References
Hutcheson, KA, Lewin, JS, Barringer, DA et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer. 2012;118(23):5793–9.CrossRefGoogle ScholarPubMed
Awan, MJ, Mohamed, ASR, Lewin, JS et al. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison. Oral Oncol. 2014;50(8):746–52.CrossRefGoogle ScholarPubMed
Thompson, EO, Smoker, WR. Hypoglossal nerve palsy: a segmental approach. Radiographics. 1994;14(5):939–58.CrossRefGoogle ScholarPubMed
References
Titulaer, MJ, Maddison, P, Sont, JK et al. Clinical Dutch–English Lambert–Eaton Myasthenic Syndrome (LEMS) Tumor Association Prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol. 2011;29(7):902–8.CrossRefGoogle ScholarPubMed
Oh, SJ. Neuromuscular junction disorders beyond myasthenia gravis. Curr Opin Neurol. 2021;34(5):648–57.CrossRefGoogle ScholarPubMed
Titulaer, MJ, Lang, B, Verschuuren, JJGM. Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10(12):1098–107.CrossRefGoogle ScholarPubMed
References
Gilden, D. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Reports. 2013;13(9):374.CrossRefGoogle ScholarPubMed
Da Costa Monsanto, R, Bittencourt, AG, Bobato Neto, NJ et al. Treatment and prognosis of facial palsy on Ramsay Hunt syndrome: results based on a review of the literature. Int Arch Otorhinolaryngol. 2016;20(4):394–400.Google Scholar
Public Health England. Shingles (Herpes Zoster): The Green Book. chapter 28a. 2021. 1–15 p. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1012943/Green_book_of_immunisation_28a_Shingles.pdf.Google Scholar
References
Almaani, S, Fussner, LA, Brodsky, S, Meara, AS, Jayne, D. ANCA-associated vasculitis: an update. J Clin Med. 2021;10(7):1446.CrossRefGoogle ScholarPubMed
Collins, M, Dyck, P, Gronseth, G et al. Peripheral nerve society guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non- systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst. 2010;15:176–84.CrossRefGoogle ScholarPubMed
Grayson, PC, Ponte, C, Suppiah, R et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification criteria for eosinophilic granulomatosis with polyangiitis. Arthrit. & Rheumatol. 2022;74(3):386–92.Google ScholarPubMed
Guillevin, L, Pagnoux, C, Seror, R et al. The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the french vasculitis study group (FVSG) cohort. Medicine (Balt). 2011;90(1):19–27.CrossRefGoogle Scholar
Guntur, VP, Manka, LA, Denson, JL et al. Benralizumab as a steroid-sparing treatment option in eosinophilic granulomatosis with polyangiitis. J Allergy Clin Immunol. 2021;9(3):1186–93.Google ScholarPubMed
References
Willison, HJ, Jacobs, BC, van Doorn, PA. Guillain–Barré syndrome. Lancet. 2016;388(10045):717–27.CrossRefGoogle ScholarPubMed
Leonhard, SE, Mandarakas, MR, Gondim, FAA et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol 2019;15(11):671–83.CrossRefGoogle ScholarPubMed
Chen, Y, Zhang, J, Chu, X, Xu, Y, Ma, F. Vaccines and the risk of Guillain–Barré syndrome. Eur J Epidemiol. 2020;35(4):363–70.CrossRefGoogle ScholarPubMed
References
Carr, AS, Cardwell, CR, McCarron, P, McConville, J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10(46).CrossRefGoogle ScholarPubMed
Ståhlberg, E, Trontelj, JV. Single Fibre Electromyography. Old Woking: Mirvalle Press, 1979.CrossRefGoogle Scholar
Oosterhuis, HJGH. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry. 1989;52(10):1121–7.CrossRefGoogle ScholarPubMed
References
Fisse, AL, Motte, J, Grüter, T, Sgodzai, M, Pitarokoili, K, Gold, R. Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy. Neurol Res Pract. 2020;2(42).CrossRefGoogle ScholarPubMed
Mauermann, ML, Burns, TM. Pearls and oy-sters: evaluation of peripheral neuropathies. Neurology. 2009;72(6):e28–31.CrossRefGoogle ScholarPubMed
van den Bergh, PYK, van Doorn, PA, Hadden, RDM et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force – second revision. Eur J Neurol. 2021;28(11):3556–83.CrossRefGoogle ScholarPubMed
References
Davies, BM, Mowforth, OD, Smith, EK, Kotter, MRN. Degenerative cervical myelopathy. BMJ. 2018;360:8–11.Google ScholarPubMed
McCarron, MO, Flynn, PA, Pang, KA, Hawkins, SA. Traumatic Brown-Séquard-plus syndrome. Arch Neurol. 2001;58:1470–2.CrossRefGoogle ScholarPubMed
Theodore, N. Degenerative cervical spondylosis. N Engl J Med. 2020;383(2):159–68.CrossRefGoogle ScholarPubMed
Mariano, R, Flanagan, EP, Weinshenker, BG, Palace, J. A practical approach to the diagnosis of spinal cord lesions. Pract Neurol. 2018;18(3):187–200.CrossRefGoogle Scholar